-
HRTX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Heron Therapeutics (HRTX)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 25.74 mm | 25.74 mm | 25.74 mm | 25.74 mm | 25.74 mm | 25.74 mm |
Cash burn (monthly) | (no burn) | 759.83 k | 1.49 mm | 2.16 mm | (no burn) | 691.17 k |
Cash used (since last report) | n/a | 3.24 mm | 6.33 mm | 9.20 mm | n/a | 2.94 mm |
Cash remaining | n/a | 22.50 mm | 19.41 mm | 16.54 mm | n/a | 22.80 mm |
Runway (months of cash) | n/a | 29.6 | 13.1 | 7.7 | n/a | 33.0 |
13F holders | Current |
---|---|
Total holders | 174 |
Opened positions | 23 |
Closed positions | 39 |
Increased positions | 65 |
Reduced positions | 38 |
13F shares | Current |
---|---|
Total value | 236.50 bn |
Total shares | 134.42 mm |
Total puts | 94.90 k |
Total calls | 80.40 k |
Total put/call ratio | 1.2 |
Largest owners | Shares | Value |
---|---|---|
Rubric Capital Management | 26.71 mm | $53.16 bn |
Adage Capital Partners GP, L.L.C. | 8.85 mm | $17.61 bn |
Adage Capital Management | 8.85 mm | $15.93 mm |
Vanguard | 8.72 mm | $17.35 bn |
BlackRock | 8.53 mm | $16.98 bn |
Velan Capital Investment Management | 6.99 mm | $13.90 bn |
Tejara Capital | 5.31 mm | $10.56 bn |
D. E. Shaw & Co. | 4.38 mm | $8.73 bn |
Palisade Capital Management | 3.99 mm | $7.94 bn |
Tang Capital Partners | 3.76 mm | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Jan 25 | William P Forbes | RSU Common Stock | Grant | Acquire A | No | No | 0 | 187,110 | 0.00 | 187,110 |
31 Jan 25 | William P Forbes | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.7 | 374,220 | 636.17 k | 374,220 |
31 Jan 25 | Collard Craig A | RSU Common Stock | Grant | Acquire A | No | No | 0 | 556,620 | 0.00 | 556,620 |
31 Jan 25 | Collard Craig A | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.7 | 1,113,240 | 1.89 mm | 1,113,240 |
31 Jan 25 | Ira Duarte | RSU Common Stock | Grant | Acquire A | No | No | 0 | 187,110 | 0.00 | 187,110 |
31 Jan 25 | Ira Duarte | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.7 | 374,220 | 636.17 k | 374,220 |
31 Jan 25 | Christian Waage | Common Stock | Grant | Acquire A | No | No | 0 | 17,950 | 0.00 | 84,130 |
31 Jan 25 | Christian Waage | Stock Option Common Stock | Grant | Acquire A | No | No | 1.7 | 35,900 | 61.03 k | 35,900 |
31 Jan 25 | Susan Rodriguez | Common Stock | Grant | Acquire A | No | No | 0 | 17,950 | 0.00 | 87,180 |
31 Jan 25 | Susan Rodriguez | Stock Option Common Stock | Grant | Acquire A | No | No | 1.7 | 35,900 | 61.03 k | 35,900 |